Roivant Sciences (ROIV) Non-Current Assets (2021 - 2026)

Roivant Sciences (ROIV) posted Non-Current Assets of $153000.0 for Q1 2026, down 100.0% on a QoQ basis from $4.3 billion in Q4 2025, and down 24.26% year-over-year from $202000.0 in Q1 2025.

Roivant Sciences (ROIV) Non-Current Assets (2021 - 2026) Analysis & Trends

Roivant Sciences' Non-Current Assets history runs 6 years deep, the most recent figure standing at $153000.0 for Q1 2026.

  • Quarterly Non-Current Assets fell 24.26% year-over-year to $153000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $153000.0 (down 24.26% YoY) and the FY2026 annual result came in at $153000.0, down 24.26% from the prior year.
  • Non-Current Assets was $153000.0 for Q1 2026 at Roivant Sciences, down from $4.3 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $4.3 billion in Q4 2025 and bottomed at $153000.0 in Q1 2026.
  • A 5-year average of $837.3 million and a median of $513.9 million in 2023 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2023 — Non-Current Assets soared 257.11% — and 2025, when it plunged 98.6%.
  • Roivant Sciences' Non-Current Assets stood at $556.7 million in 2022, then surged by 257.11% to $2.0 billion in 2023, then gained by 17.73% to $2.3 billion in 2024, then jumped by 83.05% to $4.3 billion in 2025, then slumped by 100.0% to $153000.0 in 2026.
  • Business Quant data shows ROIV's Non-Current Assets at $153000.0 in Q1 2026, $4.3 billion in Q4 2025, and $551.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Roivant Sciences 24.35 Bn 25.12 Bn - 153,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 153,000.00
Dec 31, 2025 4.28 Bn
Sep 30, 2025 550.95 Mn
Jun 30, 2025 416.85 Mn
Mar 31, 2025 202,000.00
Dec 31, 2024 2.34 Bn
Sep 30, 2024 404.91 Mn
Jun 30, 2024 494.95 Mn
Mar 31, 2024 14.42 Mn
Dec 31, 2023 1.99 Bn
Sep 30, 2023 513.92 Mn
Jun 30, 2023 575.49 Mn
Mar 31, 2023 591.02 Mn
Dec 31, 2022 556.73 Mn
Sep 30, 2022 500.67 Mn
Jun 30, 2022 560.96 Mn
Mar 31, 2022 438.61 Mn
Dec 31, 2021 511.84 Mn
Sep 30, 2021 547.15 Mn
Jun 30, 2021 397.09 Mn